ReP USP - Resultado da busca

Artigo de periodico
Harmine impairs memory performance of treated rats and nontreated cagemates (2022)
Libânio, Tânia Cristina; Eufrásio, Raí A.; Niigaki, Suzy S.; Peres, Fernanda F.; Silva, Regina H.; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Calzavara, Mariana B; Abílio, Vanessa C.
Source: Experimental and Clinical Psychopharmacology. Unidade: FMRP
Subjects: ALCALOIDES, APRENDIZAGEM, EMOÇÕES, TRANSTORNOS DA MEMÓRIA, ALUCINOGÊNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIBÂNIO, Tânia Cristina et al. Harmine impairs memory performance of treated rats and nontreated cagemates. Experimental and Clinical Psychopharmacology, v. 30, n. 6, p. 751-759, 2022Tradução . . Disponível em: https://doi.org/10.1037/pha0000525. Acesso em: 01 nov. 2024.
APA
Libânio, T. C., Eufrásio, R. A., Niigaki, S. S., Peres, F. F., Silva, R. H., Zuardi, A. W., et al. (2022). Harmine impairs memory performance of treated rats and nontreated cagemates. Experimental and Clinical Psychopharmacology, 30( 6), 751-759. doi:10.1037/pha0000525
NLM
Libânio TC, Eufrásio RA, Niigaki SS, Peres FF, Silva RH, Zuardi AW, Hallak JEC, Crippa JA de S, Calzavara MB, Abílio VC. Harmine impairs memory performance of treated rats and nontreated cagemates [Internet]. Experimental and Clinical Psychopharmacology. 2022 ; 30( 6): 751-759.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1037/pha0000525
Vancouver
Libânio TC, Eufrásio RA, Niigaki SS, Peres FF, Silva RH, Zuardi AW, Hallak JEC, Crippa JA de S, Calzavara MB, Abílio VC. Harmine impairs memory performance of treated rats and nontreated cagemates [Internet]. Experimental and Clinical Psychopharmacology. 2022 ; 30( 6): 751-759.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1037/pha0000525
Artigo de periodico
Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: the SHR strain (2018)
Diana, Mariana C.; Peres, Fernanda F.; Justi, Veronica; Bressan, Rodrigo A.; Lacerda, Acioly L. T.; Crippa, José Alexandre de Souza; Hallak, Jaime Eduardo Cecílio; Abilio, Vanesssa Costhek
Source: CNS Neuroscience and Therapeutics. Unidade: FMRP
Subjects: ESQUIZOFRENIA, RATOS, PREVENÇÃO DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DIANA, Mariana C. et al. Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: the SHR strain. CNS Neuroscience and Therapeutics, v. 24, n. 7, p. 624-632, 2018Tradução . . Disponível em: https://doi.org/10.1111/cns.12852. Acesso em: 01 nov. 2024.
APA
Diana, M. C., Peres, F. F., Justi, V., Bressan, R. A., Lacerda, A. L. T., Crippa, J. A. de S., et al. (2018). Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: the SHR strain. CNS Neuroscience and Therapeutics, 24( 7), 624-632. doi:10.1111/cns.12852
NLM
Diana MC, Peres FF, Justi V, Bressan RA, Lacerda ALT, Crippa JA de S, Hallak JEC, Abilio VC. Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: the SHR strain [Internet]. CNS Neuroscience and Therapeutics. 2018 ; 24( 7): 624-632.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1111/cns.12852
Vancouver
Diana MC, Peres FF, Justi V, Bressan RA, Lacerda ALT, Crippa JA de S, Hallak JEC, Abilio VC. Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model: the SHR strain [Internet]. CNS Neuroscience and Therapeutics. 2018 ; 24( 7): 624-632.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1111/cns.12852
Artigo de periodico
Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats (2016)
Peres, Fernanda F.; Levin, Raquel; Suiama, Mayra A.; Diana, Mariana C.; Gouvêa, Douglas A.; Almeida, Valéria; Santos, Camila M.; Lungato, Lisandro; Zuardi, Antônio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; D’Almeida, Vânia; Silva, Regina H.; Abílio, Vanessa C.
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, DOENÇA DE PARKINSON, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES, Fernanda F. et al. Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats. Frontiers in Pharmacology, v. 7, 2016Tradução . . Disponível em: https://doi.org/10.3389/fphar.2016.00343. Acesso em: 01 nov. 2024.
APA
Peres, F. F., Levin, R., Suiama, M. A., Diana, M. C., Gouvêa, D. A., Almeida, V., et al. (2016). Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats. Frontiers in Pharmacology, 7. doi:10.3389/fphar.2016.00343
NLM
Peres FF, Levin R, Suiama MA, Diana MC, Gouvêa DA, Almeida V, Santos CM, Lungato L, Zuardi AW, Hallak JEC, Crippa JA de S, D’Almeida V, Silva RH, Abílio VC. Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 nov. 01 ] Available from: https://doi.org/10.3389/fphar.2016.00343
Vancouver
Peres FF, Levin R, Suiama MA, Diana MC, Gouvêa DA, Almeida V, Santos CM, Lungato L, Zuardi AW, Hallak JEC, Crippa JA de S, D’Almeida V, Silva RH, Abílio VC. Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 nov. 01 ] Available from: https://doi.org/10.3389/fphar.2016.00343
Artigo de periodico
Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy (2016)
Peres, Fernanda F.; Levin, Raquel; Almeida, Valéria; Zuardi, Antônio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Abilio, Vanessa C.
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, MODELOS ANIMAIS, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES, Fernanda F. et al. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy. Frontiers in Pharmacology, v. 7, 2016Tradução . . Disponível em: https://doi.org/10.3389/fphar.2016.00303. Acesso em: 01 nov. 2024.
APA
Peres, F. F., Levin, R., Almeida, V., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A. de S., & Abilio, V. C. (2016). Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy. Frontiers in Pharmacology, 7. doi:10.3389/fphar.2016.00303
NLM
Peres FF, Levin R, Almeida V, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 nov. 01 ] Available from: https://doi.org/10.3389/fphar.2016.00303
Vancouver
Peres FF, Levin R, Almeida V, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 nov. 01 ] Available from: https://doi.org/10.3389/fphar.2016.00303
Artigo de periodico
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain (2014)
Levin, Raquel; Peres, Fernanda F.; Almeida, Valéria; Calzavara, Mariana B.; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Abílio, Vanessa C.
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: ESQUIZOFRENIA, TERAPÊUTICA MÉDICA, CANNABIS, SISTEMA NERVOSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEVIN, Raquel et al. Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain. Frontiers in Pharmacology, v. 5, 2014Tradução . . Disponível em: https://doi.org/10.3389/fphar.2014.00010. Acesso em: 01 nov. 2024.
APA
Levin, R., Peres, F. F., Almeida, V., Calzavara, M. B., Zuardi, A. W., Hallak, J. E. C., et al. (2014). Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain. Frontiers in Pharmacology, 5. doi:10.3389/fphar.2014.00010
NLM
Levin R, Peres FF, Almeida V, Calzavara MB, Zuardi AW, Hallak JEC, Crippa JA de S, Abílio VC. Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain [Internet]. Frontiers in Pharmacology. 2014 ; 5[citado 2024 nov. 01 ] Available from: https://doi.org/10.3389/fphar.2014.00010
Vancouver
Levin R, Peres FF, Almeida V, Calzavara MB, Zuardi AW, Hallak JEC, Crippa JA de S, Abílio VC. Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain [Internet]. Frontiers in Pharmacology. 2014 ; 5[citado 2024 nov. 01 ] Available from: https://doi.org/10.3389/fphar.2014.00010
Artigo de periodico
Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain (2014)
Almeida, Valéria; Peres, Fernanda F.; Levin, Raquel; Suiama, Mayra A.; Calzavara, Mariana B.; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Abilio, Vanessa Costhek
Source: Schizophrenia Research. Unidade: FMRP
Subjects: CANNABIS (COMPONENTES), MODELOS ANIMAIS DE DOENÇAS, ESQUIZOFRENIA (QUIMIOTERAPIA;FISIOPATOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Valéria et al. Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain. Schizophrenia Research, v. 153, n. 1-3, p. 150-159, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.schres.2014.01.039. Acesso em: 01 nov. 2024.
APA
Almeida, V., Peres, F. F., Levin, R., Suiama, M. A., Calzavara, M. B., Zuardi, A. W., et al. (2014). Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain. Schizophrenia Research, 153( 1-3), 150-159. doi:10.1016/j.schres.2014.01.039
NLM
Almeida V, Peres FF, Levin R, Suiama MA, Calzavara MB, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain [Internet]. Schizophrenia Research. 2014 ; 153( 1-3): 150-159.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.schres.2014.01.039
Vancouver
Almeida V, Peres FF, Levin R, Suiama MA, Calzavara MB, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain [Internet]. Schizophrenia Research. 2014 ; 153( 1-3): 150-159.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.schres.2014.01.039

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies

Indexado em